If you have been reading about Water activity and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-07-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Industrial production begins with whey protein concentrate or isolate dispersed in water. Selected proteases, such as trypsin, pepsin, or microbial enzymes, are added under controlled pH and temperature. Hydrolysis continues until a target hydrolysis level is reached, after which heat or pH adjustment inactivates the enzyme. Ultrafiltration, diafiltration, and ion exchange may remove larger peptides, salts, or residual lactose. The liquid is then concentrated and spray-dried into powder. Processing choices influence peptide size, bitterness, mineral content, and microbial quality.
Analytical control focuses on protein content, hydrolysis extent, molecular weight distribution, and residual intact protein. Kjeldahl or Dumas methods measure total nitrogen, while size-exclusion chromatography or mass spectrometry estimates peptide profiles. Sodium dodecyl sulfate polyacrylamide gel electrophoresis can show remaining intact proteins, though small peptides may not resolve. Enzyme-linked immunosorbent assays are used to assess residual allergenic proteins in some contexts. Because no single method captures all relevant features, manufacturers combine several assays and report values against internal specifications.
Stability depends on moisture, temperature, oxygen, and packaging. Powdered hydrolysate generally requires cool, dry storage and protection from humidity because peptides can absorb water and undergo Maillard reactions with residual lactose. Higher temperatures can increase bitterness, discoloration, and loss of solubility over time, while liquid hydrolysate formats are more perishable and may need refrigeration or preservatives. Shelf-life studies typically monitor moisture, color, pH, protein solubility, and microbial counts. Exact stability limits vary by peptide profile, packaging, and water activity, so general rules should be treated as approximate.
Laboratories characterize whey protein hydrolysate by several complementary methods. Total nitrogen or Kjeldahl analysis estimates crude protein, while amino acid analysis gives a more detailed composition. Size-exclusion chromatography and mass spectrometry separate peptides by molecular weight and can reveal the distribution of chain lengths. Degree of hydrolysis is often calculated from free amino groups using trinitrobenzenesulfonic acid or o-phthaldialdehyde assays. No single measurement captures all relevant properties, so specifications usually combine protein content, peptide profile, moisture, ash, and microbial limits.
Storage stability depends on moisture, temperature, oxygen, and packaging. Dry hydrolysate powders are typically stable for months to years when kept cool and sealed, but they can absorb water and cake if exposed to humid air. Higher temperatures accelerate Maillard reactions between peptides and residual sugars, leading to browning and flavor changes. Lipid oxidation can occur if residual fat is present, producing off-odors. Once a powder is reconstituted, microbial growth becomes a concern, so liquid forms require refrigeration or other preservation steps.
Quality control for hydrolysates often includes allergen and contaminant checks. Because whey is a milk-derived ingredient, milk protein residues may remain, and the extent to which hydrolysis reduces allergenic potential is product-specific and not fully predictable. Tests may screen for heavy metals, melamine, pesticides, and microbial indicators. Enzyme residues and processing aids are also monitored when regulations require it. Batch-to-batch consistency is assessed through peptide mapping or functional tests, since small process changes can alter taste, solubility, or nutritional performance.
| Property | Value | Notes |
|---|---|---|
| Moisture content | ≤ 6% for powder | Lower moisture supports shelf stability |
| Water activity | Often below 0.3 | Higher values increase caking and browning |
| Typical storage temperature | 15–25 °C | Cool, dry, protected from humidity |
| Common analytical method | Size-exclusion chromatography | Estimates peptide molecular weight distribution |
| Bulk density | 0.3–0.6 g/mL | Depends on spray-drying and particle size |
Advanced peptide profiling uses liquid chromatography coupled with mass spectrometry to identify fragments and assess batch consistency. Amino acid analysis after acid hydrolysis quantifies the building blocks and can reveal deviations from expected composition. Residual enzyme activity may be monitored in products where active enzymes are undesirable. Allergen tests often use immunoassays for beta-lactoglobulin, but hydrolysis can reduce or alter epitope recognition, so negative results do not prove absence of allergenic potential. Physical tests include particle size, bulk density, and reconstitution behavior.
Regulatory and labeling frameworks vary by country. In the United States, whey protein hydrolysate may be regulated as a food ingredient or a dietary supplement ingredient depending on intended use. In the European Union, it falls under general food law, with additional rules for infant formula and foods for special medical purposes. A claim of hypoallergenicity is not established by hydrolysis alone and generally requires clinical evidence. Open questions remain about how degree of hydrolysis relates to bitterness, nitrogen absorption, and residual allergenicity across different products and processing methods.
Quality control includes verifying identity, protein content, degree of hydrolysis, and absence of contaminants. Because hydrolysates are often used in foods and supplements, regulations may treat them as food ingredients rather than drugs. Allergen labeling rules can vary, and highly hydrolyzed products are sometimes considered less allergenic, but this depends on peptide size and clinical testing. Sourcing documents should link each lot to raw whey, enzymes, and processing conditions. Independent verification is useful because analytical results can shift with method and laboratory.
Laboratories characterize whey protein hydrolysate using several complementary methods. Nitrogen determination estimates total protein, while size-exclusion chromatography and mass spectrometry reveal peptide size distributions. Degree of hydrolysis can be calculated from free amino groups, pH change, or osmolarity, but each approach has assumptions. Moisture, ash, and mineral content are also measured because they affect shelf life and reconstitution. No single test fully describes a hydrolysate, so specifications usually combine several results.
Storage stability depends on moisture, temperature, and exposure to oxygen. Dry hydrolysate powders are hygroscopic and can clump or cake when humidity is high. Moisture also promotes Maillard reactions between peptides and residual lactose, leading to browning and flavor changes. Cool, dry, sealed storage slows these reactions, while prolonged warmth can increase off-flavors and reduce solubility. Stability studies often track color, moisture, free amino groups, and microbial load over time to estimate shelf life.
=== Retinoic acids and photodamage === UV radiation decreases the expression of both retinoic acid receptors and retinoid x receptors in human skin, thereby resulting in a complete loss of the induction of RA-responsive genes. It also leads to an increase in activity of the AP-1 pathway, increasing MMP activity and thus resulting in a functional deficiency of vitamin A in the skin.
China's Atomic Energy Authority rates the China Experimental Fast Reactor at 65 MW thermal and 20 MW electrical. It first reached criticality in 2010 and supplied electricity to the grid in 2011. China initiated a research and development project in thorium molten-salt thermal breeder-reactor technology (liquid fluoride thorium reactor), formally announced at the Chinese Academy of Sciences annual conference in 2011. Its ultimate target was to investigate and develop a thorium-based molten salt nuclear system over about 20 years. In November 2025, the Chinese Academy of Sciences reported thorium-to-uranium fuel conversion in an experimental molten-salt reactor built by its Shanghai Institute of Applied Physics. The institute described a goal of demonstrating a 100-megawatt project by 2035.
==== Tax deduction for energy efficient commercial buildings ==== The tax credit for energy efficient commercial buildings is no longer available for any property if the construction begins after June 30, 2026.
Sources: en.wikipedia.org
=== Therapeutics === The small size and stability profile of Affimers combined with their human origin confer drug-like properties. This may represent advantages over antibodies in terms of tissue penetration, for example in solid tumours where Avacta are developing PD-L1 inhibitors as alternatives to Opdivo and Yervoy, though requires half life modification to prevent rapid excretion through the kidney. Affimers can be conjugated to form multimers for the design of therapeutics. Examples include the production of multi-specific Affimer molecules to albumin binders to increase their half-life in vivo and for use as the targeting moiety in chimeric receptors or modified to carry a toxin in Affimer-drug conjugates. Affimers as therapeutics are in discovery and preclinical development to tackle cancer, both via CAR-T cell therapy and as checkpoint inhibitors. Early studies using ex vivo human samples showed low immunogenicity associated with the Affimer scaffold, at levels comparable to a marketed antibody therapeutic. Furthermore, initial preclinical studies showed good efficacy and tolerability of the anti-PDL1 immuno-oncology Affimers in mice. It is anticipated that IND filing for the first Affimer therapeutic will occur in 2023.
a direct effect upon a pathogen, such as antibody-initiated complement-dependent bacteriolysis, opsonization, phagocytosis and killing, as occurs for some bacteria, neutralization of viruses so that these organisms cannot enter cells, or by T lymphocytes, which will kill a cell parasitized by a microorganism. The immune system response to a microorganism often causes symptoms such as a high fever and inflammation, and has the potential to be more devastating than direct damage caused by a microbe. Resistance to infection (immunity) may be acquired following a disease, by asymptomatic carriage of the pathogen, by harboring an organism with a similar structure (crossreacting), or by vaccination. Knowledge of the protective antigens and specific acquired host immune factors is more complete for primary pathogens than for opportunistic pathogens. There is also the phenomenon of herd immunity which offers a measure of protection to those otherwise vulnerable people when a large enough proportion of the population has acquired immunity from certain infections. Immune resistance to an infectious disease requires a critical level of either antigen-specific antibodies and/or T cells when the host encounters the pathogen. Some individuals develop natural serum antibodies to the surface polysaccharides of some agents although they have had little or no contact with the agent, these natural antibodies confer specific protection to adults and are passively transmitted to newborns.
==== Donald Trump ==== In 1999, Hitchens wrote a profile of future president Donald Trump for The Sunday Herald. Trump had expressed interest in running in the 2000 presidential election as a candidate for the Reform Party. Of Trump, Hitchens said, "Because the man with many monikers in many ways embodies his country and because this election cycle is now so absurd, and so much up for grabs, it is unwise to exclude anything... The best guess has to be that here's a man who hates to be alone, who needs approval and reinforcement, who talks a better game than he plays, who is crude, hyperactive, emotional and optimistic." Hitchens had previously written that Trump demonstrated "nobody is more covetous and greedy than those who have far too much."
== Description == Croton lechleri belongs to the family Euphorbiaceae and are medium-sized trees with evergreen foliage, growing 10 to 20 meters (33 to 66 ft) in height. Despite their relatively large height, the trees have very narrow trunks, averaging a bole diameter of about 30 centimeters (0.98 feet). The leaves are large, alternate cordate (heart-shaped), bright green and 15–30 cm in width and length. The flowers are greenish-white, white or amber, which produce small, three-part capsule fruits that appear on a thin spike that measures 30–50 cm. Both the smooth, mottled bark and viscous, red, latex-rich resin excreted from the wounded trunk of the tree are used medicinally.[9] While the sap can be harvested with a tap much like natural latex from rubber trees, trees that are repeatedly tapped become vulnerable to fungal infections. Croton lechleri are native to the Amazon basin and are distributed across the tropical regions of the South American countries of Bolivia, Brazil, Colombia, Ecuador, Peru, and Venezuela. They are most commonly found in the northwest lowlands between sea level up to 1000 m in elevation, mostly in mineral-rich disturbed soil and along rivers.
Sources: en.wikipedia.org
=== San Antonio Nathan Shock Center === The San Antonio Nathan Shock Center (NSC) is one of only eight National Institute on Aging (NIA)-funded Nathan Shock Centers of Excellence in the Basic Biology of Aging in the United States. Since its establishment in 1995, the Center has served as an internationally recognized resource dedicated to advancing the fundamental biology of aging and accelerating the development of interventions that promote healthy aging and extend healthspan. The overarching mission of the Center is to identify the molecular, cellular, and physiological mechanisms that drive the aging process and translate these discoveries into strategies that delay or prevent age-associated diseases and functional decline. The San Antonio Nathan Shock Center provides investigators with an integrated, "one-stop-shop" research infrastructure that supports every stage of aging research—from experimental design and animal model development to functional phenotyping, pathology, metabolism, pharmacology, and data interpretation. This comprehensive approach enables investigators to conduct rigorous, multidisciplinary studies that examine lifespan, healthspan, and the biological mechanisms underlying aging. By integrating specialized expertise and state-of-the-art technologies within a single research environment, the Center accelerates scientific discovery while promoting collaboration among investigators locally, nationally, and internationally. The Center is organized around six highly integrated research cores that provide specialized services and scientific expertise.
===== Iron import ===== Most cell types take up iron primarily through receptor-mediated endocytosis via transferrin receptor 1 (TFR1), transferrin receptor 2 (TFR2) and GAPDH. TFR1 has a 30-fold higher affinity for transferrin-bound iron than TFR2 and thus is the main player in this process. The higher order multifunctional glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) also acts as a transferrin receptor. Transferrin-bound ferric iron is recognized by these transferrin receptors, triggering a conformational change that causes endocytosis. Iron then enters the cytoplasm from the endosome via importer DMT1 after being reduced to its ferrous state by a STEAP family reductase. Alternatively, iron can enter the cell directly via plasma membrane divalent cation importers such as DMT1 and ZIP14 (Zrt-Irt-like protein 14). Again, iron enters the cytoplasm in the ferrous state after being reduced in the extracellular space by a reductase such as STEAP2, STEAP3 (in red blood cells), Dcytb (in enterocytes) and SDR2.
Amin al-Husayni, as chairman Jamal al-Husayni, as vice-chairman Husayin al-Khalidi Emile al-Ghury Ahmed Hilmi Abd al-Baqi The United Kingdom government called the 1946–47 London Conference on Palestine in an attempt to bring peace to its Mandate territory, which began on 9 September 1946. The conference was boycotted by the AHE as well as the Jewish Agency, but was attending by Arab League states, which argued against any partition.
glutathione disulfide + protein-dithiol Thus, the two substrates of this enzyme are glutathione and protein disulfide, whereas its two products are glutathione disulfide and protein dithiol. In humans, at least one protein, TXNDC12, is thought to have enzyme activity of this type based on relatively recent data (2003). Historically, the breaking of the disulfide bonds of insulin was thought to be catalyzed by an enzyme of this class, which researcher’s called “glutathione-insulin transhydrogenase” (GIT). Later, the enzyme in question was found to be of the protein disulfide-isomerase family, leading to some ambiguity in the nomenclature. This enzyme belongs to the family of oxidoreductases, specifically those acting on a sulfur group of donors with a disulfide as acceptor. The systematic name of this enzyme class is glutathione:protein-disulfide oxidoreductase. Other names in common use include glutathione-insulin transhydrogenase, insulin reductase, reductase, protein disulfide (glutathione), protein disulfide transhydrogenase, glutathione-protein disulfide oxidoreductase, protein disulfide reductase (glutathione), GSH-insulin transhydrogenase, protein-disulfide interchange enzyme, protein-disulfide isomerase/oxidoreductase, thiol:protein-disulfide oxidoreductase, and thiol-protein disulphide oxidoreductase. This enzyme participates in glutathione metabolism.
Cyclophosphamide is a common cytotoxic drug used in this manner and is often used in conjunction with total body irradiation. Chemotherapeutic drugs may be used at high doses to permanently remove the recipient's bone marrow cells (myeloablative conditioning) or at lower doses that will prevent permanent bone marrow loss (non-myeloablative and reduced intensity conditioning). When used in non-cancer setting, the treatment is still called "chemotherapy", and is often done in the same treatment centers used for people with cancer.
Sources: en.wikipedia.org
Hydrolysis extent is often estimated by measuring the increase in soluble nitrogen or free amino groups relative to total nitrogen. The o-phthaldialdehyde method and trinitrobenzenesulfonic acid assay are common laboratory approaches. Values are method-dependent, so comparisons require the same assay and calculation.
Enzymatic cleavage can expose hydrophobic amino acid residues that interact with bitter taste receptors. The intensity depends on peptide sequence, hydrolysis extent, and further processing such as filtration or deamidation. Bitterness is not a reliable indicator of protein quality or allergenicity.
Moisture uptake, storage temperature, and packaging barrier properties are major factors. Residual lactose can participate in browning reactions when water activity and temperature rise. Shelf-life testing usually combines accelerated and real-time conditions to estimate change in color, solubility, and microbial stability.
Degree of hydrolysis is commonly estimated by quantifying free amino groups with colorimetric assays such as o-phthaldialdehyde or trinitrobenzenesulfonic acid. The result is expressed as a percentage of total peptide bonds cleaved. Because different assays can give different values, method details matter when comparing products.